Professional notice
Founded in 1981, Analysis Group is a US consultancy born on the banks of the Charles River in Boston – and from the area’s fertile field of economists – that has included competition expertise from the start. It boasts the largest amount of antitrust litigation advisory work in our survey, with experts involved in 83 separate cases.
| Global head | Martha Samuelson |
| Home jurisdiction | US |
| Total size of firm | 591 |
| Competition economists | 205 |
| % of firm specialised | 35% |
| Who’s Who Legal: Competition nominees | 4 |
| Group one | N/A |
| Group two | N/A |
| Group three | N/A |
| Group four | N/A |
| Lateral hires | 0 |
| Departures | 5 |
| Internal promotions | 5 |
In the latter half of 2016 and first half of 2017, Analysis Group worked on major cases in the healthcare, media and communications, transportation, commodities, computer software/hardware, and payment card industries. Perhaps most notably during that time, it helped the US Department of Justice win two merger trials that dealt with two very different industries and arguments.
The Department of Justice’s antitrust division retained Analysis Group while trying to block the merger between health insurers Anthem and Cigna. Economist David Dranove acted as an expert witness on market definition, the impact on market concentration, competitive effects including the loss of innovation, the impact on medical costs and entry. He testified multiple times during the trial in late 2016, providing both affirmative testimony as well as rebuttal testimony to the merging parties’ three economic experts, and ultimately secured a spot on the winning side after a Washington, DC federal district court granted the injunction and an appellate court upheld it.
Up the coast in Delaware, another Analysis Group affiliate testified for the government in another successful merger trial: the Antitrust Division’s lawsuit against the merging of radioactive waste disposal companies EnergySolutions and Waste Control Specialists. Economist John Mayo analysed market definition, finding that the proposed tie-up would substantially increase concentration in the relevant markets and would eliminate the close, head-to-head competition that has demonstrably benefited customers.
The firm also found itself on the joint defence group in multidistrict litigation, alleging that several major contact lens makers artificially inflated the prices of disposable contact lenses by using unilateral pricing policies. Affiliate Edward Snyder and president Pierre Cremieux addressed issues related to class certification. Analysis Group also continues to represent several defendants in the ongoing Optical Disk Drive Products antitrust litigation. Those merger and litigation matters only scratch the surface of the firm’s work, as it handled 14 in-depth merger reviews, 83 antitrust litigations and 15 government-facing investigations.
Antitrust has been a core focus of Analysis Group’s work since our inception in 1981. We integrate industrial organization theory, industry-specific expertise, and the latest quantitative analytical methods to understand the conduct and market dynamics at issue in antitrust litigation and merger investigations. We have demonstrated our expertise in complex assignments related to class certification, antitrust liability, antitrust damages, and the competitive effects of proposed mergers and acquisitions.
Our antitrust work covers a range of industries and markets, including high tech, financial products, manufacturing products, insurance, health care and pharmaceuticals, agriculture, and many others. Over the last decade, we have provided support to internal and external experts in some of the most significant mergers and government competition investigations, including various recent cable TV mergers and challenges to the Anthem-Cigna merger and St. Luke's acquisition of Saltzer Medical Group. We have also been involved in numerous high-profile monopolization cases involving such companies as Microsoft and Intel, as well as some of the largest cartel cases in industries including credit cards, vitamins, TFT-LCD panels, cathode ray tubes, and auto parts. Another area of focus for our recent antitrust work has been in the pharmaceutical industry, where we have been involved in a number of high-profile reverse-payment, product-hopping, and delayed generic entry matters.
In addition to our antitrust and competition work, we provide expertise in economics, finance, health care analytics, and strategy to top law firms, Fortune 500 companies, and government agencies. Our internal experts, together with our network of affiliated experts from academia, industry, and government, offer our clients exceptional depth of expertise.